CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 1 filers reported holding CHINOOK THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,214 | +116.9% | 109,656 | +30.7% | 0.00% | +200.0% |
| Q1 2023 | $1,943 | -27.3% | 83,925 | -17.7% | 0.00% | 0.0% |
| Q4 2022 | $2,671 | -99.9% | 101,941 | +10.5% | 0.00% | -50.0% |
| Q3 2022 | $1,814,000 | +2318.7% | 92,271 | +2027.5% | 0.00% | – |
| Q2 2022 | $75,000 | -45.3% | 4,337 | -48.3% | 0.00% | – |
| Q1 2022 | $137,000 | – | 8,390 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parallel Advisors, LLC | 5 | $0 | 0.00% |